| Attributes | Values |
|---|
| rdf:type
| |
| description
| - wetenschappelijk artikel (nl)
- artículu científicu espublizáu en 1984 (ast)
- articolo scientifico (pubblicato il 1984) (it)
- artigo científico (publicado na 1984) (pt)
- наукова стаття, опублікована в січні 1984 (uk)
- im Januar 1984 veröffentlichter wissenschaftlicher Artikel (de)
- artikull shkencor i botuar më 01 janar 1984 (sq)
- scientific article published on 01 January 1984 (en)
|
| publication date
| |
| publication date
| |
| language of work or name
| |
| language of work or name
| |
| author name string
| |
| author name string
| - J Lam
- B R Chaitman
- J M Scholl
- R J Ferguson
- A Pasternac
- P Wagniart
- G Brevers
- M Methe
|
| rdfs:label
| - Improved exercise tolerance after propranolol, diltiazem or nifedipine in angina pectoris: comparison at 1, 3 and 8 hours and correlation with plasma drug concentration (en)
- Improved exercise tolerance after propranolol, diltiazem or nifedipine in angina pectoris: comparison at 1, 3 and 8 hours and correlation with plasma drug concentration (nl)
- Improved exercise tolerance after propranolol, diltiazem or nifedipine in angina pectoris: comparison at 1, 3 and 8 hours and correlation with plasma drug concentration (sq)
|
| skos:prefLabel
| - Improved exercise tolerance after propranolol, diltiazem or nifedipine in angina pectoris: comparison at 1, 3 and 8 hours and correlation with plasma drug concentration (en)
- Improved exercise tolerance after propranolol, diltiazem or nifedipine in angina pectoris: comparison at 1, 3 and 8 hours and correlation with plasma drug concentration (nl)
- Improved exercise tolerance after propranolol, diltiazem or nifedipine in angina pectoris: comparison at 1, 3 and 8 hours and correlation with plasma drug concentration (sq)
|
| name
| - Improved exercise tolerance after propranolol, diltiazem or nifedipine in angina pectoris: comparison at 1, 3 and 8 hours and correlation with plasma drug concentration (en)
- Improved exercise tolerance after propranolol, diltiazem or nifedipine in angina pectoris: comparison at 1, 3 and 8 hours and correlation with plasma drug concentration (nl)
- Improved exercise tolerance after propranolol, diltiazem or nifedipine in angina pectoris: comparison at 1, 3 and 8 hours and correlation with plasma drug concentration (sq)
|
| author
| |
| author
| |
| title
| |
| title
| - Improved exercise tolerance after propranolol, diltiazem or nifedipine in angina pectoris: comparison at 1, 3 and 8 hours and correlation with plasma drug concentration (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| - 10.1016/0002-9149(84)90674-X
|
| is about
of | |
| is cites work
of | - The changing role of the exercise electrocardiogram as a diagnostic and prognostic test for chronic ischemic heart disease.
- Beta-adrenoceptor blockade and exercise. An update
- Effect of nifedipine and propranolol on blood flow, venous compliance and blood pressure in essential hypertension
- Staged septation of double inlet left ventricle
- Effects of carbon monoxide on myocardial ischemia
- Slow release nifedipine plus atenolol in chronic stable angina pectoris
- A comparison of diltiazem and atenolol in angina
- Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders
- Efficacy of nisoldipine combined with beta-adrenergic-blocking drugs in the treatment of chronic stable angina
- Measuring antianginal drug efficacy using exercise testing for chronic angina: improved exercise performance with ranolazine, a pFOX inhibitor
- Beta-adrenoceptor antagonists plus nifedipine in the treatment of chronic stable angina pectoris
- Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials
- A dose-ranging, placebo-controlled, double-blind trial of nisoldipine in effort angina: duration and extent of antianginal effects
- Diltiazem. A review of its pharmacological properties and therapeutic efficacy
- Paradoxical effect of long-term treatment of nifedipine on total ischemic load in patients with stable angina pectoris
- A randomized double-blind comparison of diltiazem and nifedipine in stable angina
- Comparison of the antianginal efficacy of four calcium antagonists and propranolol in stable angina pectoris
- Calcium channel blockers
- Nifedipine. Relationship between pharmacokinetics and pharmacodynamics
- Pharmacology of acute effort angina
- Effects of diltiazem and isosorbide-5-mononitrate, alone and in combination, on patients with stable angina pectoris
- Effect of diltiazem and propranolol on myocardial ischaemia during unrestricted daily life in patients with effort-induced chronic stable angina pectoris
- Antianginal efficacy over 24 hours and exercise hemodynamic effects of once daily sustained-release 300 mg diltiazem and 240 mg verapamil in stable angina pectoris
- Effects of nifedipine, verapamil and diltiazem on renal function
- A randomized double-blind crossover study of nicardipine and nifedipine in patients with angina pectoris and concomitant essential hypertension
- Changes in haemodynamics and left ventricular function during intravenous nifedipine infusion with and without additional propranolol in patients with coronary artery disease. A randomized, placebo controlled trial
- Studies on ergometer exercise testing. II. Effect of previous myocardial infarction, digoxin, and beta-blockade on exercise electrocardiography
- The combination of slow-release nifedipine and atenolol for stable angina
- 24-hour anti-ischaemic action with once daily nifedipine. Experience obtained with a fatty-alcohol matrix tablet in patients with coronary artery disease
- Evaluation of the antianginal effect of nifedipine: influence of formulation dependent pharmacokinetics
- Effect of carteolol on silent myocardial ischemia, variability in heart rate, and the pain-modulating system
|
| is cites work
of | |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)